VP.S ENCORE® PEDS™

About Vascular Perfusion Solutions

Vascular Perfusion Solutions is targeting a critical bottleneck in heart transplantation: the limited 4-6 hour preservation window with standard cold storage. The company's VP.S ENCORE® system is engineered to be a portable, cost-effective, and user-friendly device that uses a blood-free perfusate to potentially extend heart viability up to 8 hours, aiming to reduce organ discard rates and expand geographic matching. With FDA Breakthrough Device status secured in 2021 and preclinical data suggesting preservation up to 24 hours, the company is positioning its technology as a pragmatic solution to increase transplant volumes. Its long-term vision includes platform application for other organs and advanced therapies.

Therapeutic Areas